查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954638

全球體外膜氧合（ECMO）設備市場：市場規模、佔有率、成長率、依類型和應用劃分的產業分析、區域洞察及未來預測（2026-2034）

Extracorporeal Membrane Oxygenation Machine Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 125 Pages | 商品交期: 請詢問到貨日

價格

體外膜氧合（ECMO）設備市場成長驅動因子

2025年全球體外膜氧合（ECMO）設備市場規模為5.528億美元，預計2026年將成長至5.748億美元。此外，預計在預測期（2026-2034年）內，該市場將以4.06%的複合年增長率成長，到2034年達到7.9005億美元。

北美地區在全球ECMO設備市場中佔領先地位，2025年市佔率為49.36%，主要得益於該地區心血管疾病的高發生率。 手術數量不斷增加，以及主要市場參與者的強大影響力。

體外膜氧合（ECMO）是一種先進的生命維持設備，可在體外為血液提供氧氣和循環支持。它主要以兩種模式運作：靜脈-動脈（VA）模式和靜脈-靜脈（VV）模式。這項技術廣泛應用於呼吸衰竭、急性呼吸窘迫症候群（ARDS）、肺栓塞、心因性休克、開胸手術併發症、重症 COVID-19 患者。

市場驅動因素

心血管和呼吸系統疾病的成長趨勢

心血管疾病（CVD）和呼吸系統疾病負擔的加重是推動 ECMO 設備需求的主要因素。在全球範圍內，心血管疾病每年導致約 1860 萬人死亡。 此外，急性呼吸窘迫症候群 (ARDS)、慢性阻塞性肺病 (COPD) 和呼吸衰竭的病例持續增加，對高階生命維持系統的需求也隨之增長。

美國每年報告約 19 萬例 ARDS 病例。此外，全球每年約進行 4,600 例肺移植手術，其中約 80% 在北美和歐洲進行。這些因素顯著推動了體外膜氧合 (ECMO) 設備市場的擴張。

技術進步

持續的技術創新，例如小型化氧合裝置、先進的旋轉泵、雙腔插管、改進的迴路塗層和磁懸浮離心泵，正在改善患者的治療效果。 現代體外膜氧合（ECMO）系統能夠實現快速預充、降低血流阻力、減少血漿滲漏並最大限度減少併發症，因此在醫院和重症監護室的應用日益廣泛。

新冠疫情的影響

由於呼吸和循環支援設備的需求增加，新冠疫情對ECMO設備市場產生了正面影響。醫院擴大了ECMO設施，以治療新冠重症患者。主要製造商報告稱，由於ECMO系統需求增加，疫情期間收入有所增長。

2020年和2021年使用量的激增加強了ECMO設備的全球部署，確立了其作為重症監護室關鍵基礎設施的地位。

市場限制因子

儘管需求強勁，但ECMO系統的高昂成本限制了其在發展中國家的部署。 在美國，ECMO系統的價格在15.2萬美元到17萬美元之間；在印度，價格在3.5萬美元到4.8萬美元之間。包括耗材和專業人員在內的總治療費用進一步加劇了負擔能力的挑戰，尤其是在低收入醫療體系中。

市場區隔分析

依類型

此市場細分分為靜脈-動脈（VA）系統和靜脈-靜脈（VV）系統。

  • 靜脈-動脈系統廣泛應用於心臟支持和先天性心臟病病例，預計2025年將佔最大的市場佔有率，達到59.01%。
  • 由於呼吸衰竭病例數量的增加以及其在新冠肺炎（COVID-19）中的廣泛應用，靜脈-靜脈系統預計將保持穩定增長。

依應用領域劃分

市場區隔分為成人、兒童和新生兒。

  • 預計到 2026 年，成人市場將佔主導地位，市佔率達 76.46%，主要得益於成人心臟和呼吸系統疾病的高發生率。
  • 預計兒童市場將穩定成長，這主要歸因於肺炎和先天性心臟病病例的增加。
  • 由於手術相關的併發症和風險因素，新生兒市場呈現溫和成長。

區域洞察

北美

北美在先進的醫療保健基礎設施和強大的製造商網路的支持下，預計將在 2025 年引領市場。 由於美國心血管疾病死亡率高，其持續推動區域成長。

歐洲

預計到2034年，歐洲將經歷顯著成長，這主要得益於有利的報銷政策和研發投入的增加。

亞太地區

預計2026年至2034年，亞太地區的複合年增長率（CAGR）最高，這主要得益於體外膜氧合（ECMO）中心的擴張、龐大的患者群體以及中國、日本和印度醫療保健投資的增加。

拉丁美洲、中東和非洲

預計這些地區將經歷適度增長，這主要得益於醫療保健基礎設施的改善和先進醫療技術的日益普及。

北美仍將維持領先地位，2025年市佔率將達到49.36%，但預計亞太地區在預測期內將實現最快成長。 儘管高昂的系統成本仍然是一個挑戰，但持續的技術進步和不斷擴大的醫療保健投資預計將維持市場長期擴張至2034年。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：主要發現

  • 主要國家的心臟和肺移植數量（2025年）
  • 新產品發布
  • 主要產業發展：重大併購與合作
  • COVID-19疫情的影響體外膜氧合（ECMO）設備市場

第五章 全球體外膜氧合（ECMO）設備市場分析、洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依類型劃分
    • VA（靜脈-動脈）ECMO設備
    • VV（靜脈-靜脈）ECMO設備
  • 市場分析、洞察與預測：依應用劃分
    • 成人
    • 兒科
    • 新生兒
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東及非洲

第六章：北美體外膜氧合（ECMO）設備市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲體外膜氧合（ECMO）設備市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 其他歐洲地區

第八章 第九章：分析、洞察與預測亞太地區體外膜氧合（ECMO）設備市場（2021-2034）

  • 依國家劃分
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
    • 東南亞
    • 其他亞太地區

第九章：拉丁美洲體外膜氧合（ECMO）設備市場（2021-2034）分析、洞察與預測

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家
第十章：拉丁美洲體外膜氧合（ECMO）設備市場分析、洞察與預測中東和非洲（2021-2034）
  • 依國家劃分
    • 海灣合作委員會 (GCC)
    • 南非
    • 其他中東和非洲國家/地區

第十一章 競爭分析

  • 全球市佔率分析（2025）
  • 市場主要參與者概覽（概述、產品、SWOT 分析、近期發展、策略、財務狀況（基於現有資訊））
    • Getinge AB
    • LivaNova PLC
    • Xenios AG (Fresenius Medical Care)
    • EUROSETS
    • ABIOMED
    • Medtronic
    • NIPRO
    • Spectrum Medical
    • Terumo Corporation
Product Code: FBI100369

Growth Factors of extracorporeal membrane oxygenation (ECMO) machine Market

The global extracorporeal membrane oxygenation (ECMO) machine market was valued at USD 552.8 million in 2025 and is projected to grow to USD 574.8 million in 2026. The market is further expected to reach USD 790.05 million by 2034, exhibiting a CAGR of 4.06% during the forecast period (2026-2034).

North America dominated the global ECMO machine market with a 49.36% market share in 2025, driven by the high prevalence of cardiovascular diseases, rising number of surgical procedures, and strong presence of leading market players.

ECMO is an advanced life-support system used to oxygenate blood outside the body and provide circulatory support. It operates primarily in two modes: Veno-Arterial (VA) and Veno-Venous (VV). The technology is widely used in patients suffering from respiratory failure, acute respiratory distress syndrome (ARDS), pulmonary embolism, cardiogenic shock, open-heart surgery complications, and severe COVID-19 cases.

Market Drivers

Rising Prevalence of Cardiovascular and Respiratory Diseases

The growing burden of cardiovascular diseases (CVDs) and respiratory disorders is a major factor driving ECMO machine demand. Globally, cardiovascular diseases account for approximately 18.6 million deaths annually. Additionally, ARDS, chronic obstructive pulmonary disease (COPD), and respiratory failure cases continue to rise, increasing the need for advanced life-support systems.

In the U.S., around 190,000 ARDS cases are reported annually. Furthermore, nearly 4,600 lung transplant procedures are performed globally each year, with North America and Europe accounting for nearly 80% of the total. These factors significantly contribute to the expansion of the ECMO machine market.

Technological Advancements

Continuous innovations such as miniaturized oxygenators, advanced rotary pumps, dual-lumen cannula, improved circuit coatings, and magnetic levitation centrifugal pumps have enhanced patient outcomes. Modern ECMO systems offer rapid priming, lower blood flow resistance, reduced plasma leakage, and minimized complications, encouraging higher adoption across hospitals and critical care units.

COVID-19 Impact

The COVID-19 pandemic positively impacted the ECMO machine market due to increased demand for respiratory and circulatory support. Hospitals expanded ECMO capacity to treat critically ill COVID-19 patients. Major players reported revenue growth during the pandemic due to increased demand for ECMO systems.

The surge in usage during 2020 and 2021 strengthened the adoption of ECMO machines globally and established them as critical infrastructure in intensive care units.

Market Restraints

Despite strong demand, the high cost of ECMO systems limits adoption in developing economies. In the U.S., an ECMO system costs between USD 152,000 and USD 170,000, while in India, prices range from USD 35,000 to USD 48,000. The total procedural cost, including consumables and skilled personnel, further increases affordability challenges, especially in low-income healthcare systems.

Segmentation Analysis

By Type

The market is segmented into Veno-Arterial (VA) and Veno-Venous (VV) systems.

  • The Veno-Arterial segment held the largest share of 59.01% in 2025, owing to its extensive use in cardiac support and congenital heart defect cases.
  • The Veno-Venous segment is expected to grow steadily due to increasing respiratory failure cases and its widespread use during COVID-19.

By Application

The market is segmented into adult, pediatric, and neonatal.

  • The adult segment dominated with a 76.46% share in 2026, driven by high incidence of cardiac and respiratory disorders in adults.
  • The pediatric segment is expected to grow steadily due to rising pneumonia and congenital heart disease cases.
  • The neonatal segment shows moderate growth due to procedural complications and risk factors.

Regional Insights

North America

North America led the market in 2025, supported by advanced healthcare infrastructure and strong manufacturer presence. The U.S. continues to drive regional growth due to high cardiovascular mortality rates.

Europe

Europe is expected to grow at a substantial rate through 2034 due to favorable reimbursement policies and increased R&D investments.

Asia Pacific

Asia Pacific is projected to witness the highest CAGR during 2026-2034, supported by expanding ECMO centers, large patient pool, and growing healthcare investments in China, Japan, and India.

Latin America & Middle East & Africa

These regions are expected to grow at a moderate pace due to improving healthcare infrastructure and increasing adoption of advanced medical technologies.

Competitive Landscape

The ECMO machine market is consolidated, with major players including Getinge AB, Terumo Corporation, Medtronic plc, LivaNova PLC, Xenios AG, EUROSETS, ABIOMED, NIPRO, and Spectrum Medical.

Companies focus on product innovation, acquisitions, and regulatory approvals to strengthen their market position. Strategic developments and expansion of product portfolios are key competitive strategies.

Conclusion

The global ECMO machine market is set to grow steadily from USD 552.8 million in 2025 to USD 574.8 million in 2026, reaching USD 790.05 million by 2034, at a CAGR of 4.06%. Growth is primarily driven by the rising prevalence of cardiovascular and respiratory diseases, increasing adoption of advanced life-support technologies, and expanding ECMO centers worldwide.

North America remains the dominant region with a 49.36% share in 2025, while Asia Pacific is expected to register the fastest growth during the forecast period. Although high system costs pose a challenge, continuous technological advancements and growing healthcare investments are expected to sustain long-term market expansion through 2034.

Segmentation By Type, Application, and Region

By Type * Veno-Arterial

  • Veno-Venous

By Application

Adult

  • Pediatric
  • Neonatal

By Region * North America (By Type, By Application, By Country)

    • U.S.
    • Canada
  • Europe (By Type, By Application, By Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, By Application, By Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, By Application, By Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa (By Type, By Application, By Country/Sub-region)
    • South Africa
    • GCC
    • Rest of Middle East and Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Heart and Lung Transplantations, By Key Countries, 2025
  • 4.2. New Product Launches
  • 4.3. Key Industry Developments - Key Mergers, Acquisitions and Partnerships
  • 4.4. Impact of COVID-19 on the Extracorporeal Membrane Oxygenation (ECMO) Machine Market

5. Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. VA (Veno-Arterial) ECMO Machine
    • 5.1.2. VV (Veno-Venous) ECMO Machine
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Adult
    • 5.2.2. Pediatric
    • 5.2.3. Neonatal
  • 5.3. Market Analysis, Insights and Forecast - By Geography
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. VA (Veno-Arterial) ECMO Machine
    • 6.1.2. VV (Veno-Venous) ECMO Machine
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Adult
    • 6.2.2. Pediatric
    • 6.2.3. Neonatal
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. VA (Veno-Arterial) ECMO Machine
    • 7.1.2. VV (Veno-Venous) ECMO Machine
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Adult
    • 7.2.2. Pediatric
    • 7.2.3. Neonatal
  • 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Scandinavia
    • 7.3.7. Rest of Europe

8. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. VA (Veno-Arterial) ECMO Machine
    • 8.1.2. VV (Veno-Venous) ECMO Machine
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Adult
    • 8.2.2. Pediatric
    • 8.2.3. Neonatal
  • 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. India
    • 8.3.4. South Korea
    • 8.3.5. Australia
    • 8.3.6. Southeast Asia
    • 8.3.7. Rest of Asia Pacific

9. Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. VA (Veno-Arterial) ECMO Machine
    • 9.1.2. VV (Veno-Venous) ECMO Machine
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Adult
    • 9.2.2. Pediatric
    • 9.2.3. Neonatal
  • 9.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. VA (Veno-Arterial) ECMO Machine
    • 10.1.2. VV (Veno-Venous) ECMO Machine
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Adult
    • 10.2.2. Pediatric
    • 10.2.3. Neonatal
  • 10.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.3.1. GCC
    • 10.3.2. South Africa
    • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Profiles of Players Operating in the Market (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (based on availability))
    • 11.2.1. Getinge AB
      • 11.2.1.1. Overview,
      • 11.2.1.2. Products,
      • 11.2.1.3. SWOT Analysis,
      • 11.2.1.4. Recent Developments,
      • 11.2.1.5. Strategies,
      • 11.2.1.6. financials (based on availability)
    • 11.2.2. LivaNova PLC
      • 11.2.2.1. Overview,
      • 11.2.2.2. Products,
      • 11.2.2.3. SWOT Analysis,
      • 11.2.2.4. Recent Developments,
      • 11.2.2.5. Strategies,
      • 11.2.2.6. financials (based on availability)
    • 11.2.3. Xenios AG (Fresenius Medical Care)
      • 11.2.3.1. Overview,
      • 11.2.3.2. Products,
      • 11.2.3.3. SWOT Analysis,
      • 11.2.3.4. Recent Developments,
      • 11.2.3.5. Strategies,
      • 11.2.3.6. financials (based on availability)
    • 11.2.4. EUROSETS
      • 11.2.4.1. Overview,
      • 11.2.4.2. Products,
      • 11.2.4.3. SWOT Analysis,
      • 11.2.4.4. Recent Developments,
      • 11.2.4.5. Strategies,
      • 11.2.4.6. financials (based on availability)
    • 11.2.5. ABIOMED
      • 11.2.5.1. Overview,
      • 11.2.5.2. Products,
      • 11.2.5.3. SWOT Analysis,
      • 11.2.5.4. Recent Developments,
      • 11.2.5.5. Strategies,
      • 11.2.5.6. financials (based on availability)
    • 11.2.6. Medtronic
      • 11.2.6.1. Overview,
      • 11.2.6.2. Products,
      • 11.2.6.3. SWOT Analysis,
      • 11.2.6.4. Recent Developments,
      • 11.2.6.5. Strategies,
      • 11.2.6.6. financials (based on availability)
    • 11.2.7. NIPRO
      • 11.2.7.1. Overview,
      • 11.2.7.2. Products,
      • 11.2.7.3. SWOT Analysis,
      • 11.2.7.4. Recent Developments,
      • 11.2.7.5. Strategies,
      • 11.2.7.6. financials (based on availability)
    • 11.2.8. Spectrum Medical
      • 11.2.8.1. Overview,
      • 11.2.8.2. Products,
      • 11.2.8.3. SWOT Analysis,
      • 11.2.8.4. Recent Developments,
      • 11.2.8.5. Strategies,
      • 11.2.8.6. financials (based on availability)
    • 11.2.9. Terumo Corporation
      • 11.2.9.1. Overview,
      • 11.2.9.2. Products,
      • 11.2.9.3. SWOT Analysis,
      • 11.2.9.4. Recent Developments,
      • 11.2.9.5. Strategies,
      • 11.2.9.6. financials (based on availability)

List of Tables

  • Table 01: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 02: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 03: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Region, 2021-2034
  • Table 04: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 05: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 06: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 07: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 08: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 09: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 10: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Country/Sub-region, 2021-2034
  • Table 11: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 12: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 13: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Country/Sub-region, 2021-2034
  • Table 14: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 15: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 16: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Country/Sub-region, 2021-2034
  • Table 17: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 18: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 19: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Country, 2021-2034

List of Figures

  • Figure 01: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 02: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), By Type, 2025 & 2034
  • Figure 03: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast (USD million), by VA ECMO, 2021-2034
  • Figure 04: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast (USD million), by VV ECMO, 2021-2034
  • Figure 05: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), By Application, 2025 & 2034
  • Figure 06: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast (USD million), by Pediatrics, 2021-2034
  • Figure 07: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast (USD million), by Neonatal, 2021-2034
  • Figure 08: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast (USD million), by Adults, 2021-2034
  • Figure 09: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), By Region, 2025 & 2034
  • Figure 10: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Type, 2025 & 2034
  • Figure 11: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Type, 2025
  • Figure 12: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Application, 2025 & 2034
  • Figure 13: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Application, 2025
  • Figure 14: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Country, 2025 & 2034
  • Figure 15: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Country, 2025
  • Figure 16: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Type, 2025 & 2034
  • Figure 17: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Type, 2025
  • Figure 18: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Application, 2025 & 2034
  • Figure 19: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Application, 2025
  • Figure 20: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Country/Sub-region, 2025 & 2034
  • Figure 21: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Country/Sub-region, 2025
  • Figure 22: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Country/Sub-region, 2025 & 2034
  • Figure 27: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Country/Sub-region, 2025
  • Figure 28: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Type, 2025 & 2034
  • Figure 29: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Type, 2025
  • Figure 30: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Application, 2025 & 2034
  • Figure 31: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Application, 2025
  • Figure 32: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Country/Sub-region, 2025 & 2034
  • Figure 33: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Country/Sub-region, 2025
  • Figure 34: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Type, 2025 & 2034
  • Figure 35: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Type, 2025
  • Figure 36: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Application, 2025 & 2034
  • Figure 37: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Application, 2025
  • Figure 38: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Country/Sub-region, 2025 & 2034
  • Figure 39: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Country/Sub-region, 2025
  • Figure 40: Global Extra Corporeal Membrane Oxygenation (ECMO) Machine Market Share (%), 2025